Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead

No. Ozempic is not available over the counter in the United States, and neither is any other GLP‑1 drug. Every one of them, from the Ozempic and Wegovy pens to Mounjaro, Zepbound, the Wegovy pill, Foundayo and generic liraglutide, is a prescription drug whose label carries “Rx only”.^{[1][3][5][21]} What sells without a prescription under a GLP‑1 name is one of four things: a supplement that contains no GLP‑1 drug, a patch or drops with no shown way into the body, a “research” vial the FDA says is sold illegally, or a counterfeit. No GLP‑1 maker has publicly moved to take any of these drugs over the counter.

The short answer, drug by drug

The National Library of Medicine’s DailyMed database holds 51 current and archived labels for drugs containing semaglutide, tirzepatide, orforglipron, liraglutide, dulaglutide or exenatide. Each one, from the semaglutide pens and pills^[1][2][6] to the tirzepatide pens,^[3][4] is filed as a human prescription drug label, and so are the older liraglutide and dulaglutide products.^[21][22] None is filed as an over-the-counter label. Federal law requires every prescription drug’s label to bear the symbol “Rx only” before it is dispensed.^[7] An Ozempic carton reads “Rx only” next to the dose,^[1] and so does every Foundayo carton, even the lowest 0.8 mg strength.^[5]

Federal law sets what that marking means. A drug that is not safe to use without a licensed practitioner’s supervision, or that its FDA approval limits to such supervision, may be dispensed only on a prescription. Dispensing one without a prescription makes the drug misbranded under the law.^[7] That is the provision FDA cites when it writes to websites that sell semaglutide to anyone who pays.^[11]

The pills do not change this. A tablet feels like something you could pick up at a pharmacy counter, and the two approved GLP‑1 pills, the Wegovy pill and Foundayo, are often described as easier to get. They are easier to take, but they are not easier to buy: both are prescription-only, exactly like the pens.^[2][5] Our Foundayo explainer covers how the newer pill works.

What an "over-the-counter GLP-1" really is

Search for an OTC GLP‑1 and you will find plenty for sale. None of it is the drug in Ozempic or Zepbound sold legally without a prescription. It falls into four groups.

Supplements. A dietary supplement may say it supports a body function, but federal rules make its label admit that FDA has not reviewed that claim and that the product is not meant to treat or prevent any illness.^[18] Calling a capsule a GLP‑1 is marketing language, not a statement that it contains one. The ingredients and their trial results are set out one by one in GLP-1 supplements: do they work?

Patches and drops. Semaglutide and tirzepatide are large peptide molecules. Skin keeps them out, which is why GLP-1 patches do not deliver the drug. Even the approved semaglutide pill, built to be swallowed, gets only about 1% to 2% of its dose into the blood.^[2] No study has shown the same from sublingual semaglutide drops.

“Research” peptides. These are vials of powder sold with a disclaimer that they are only for lab work and must not be taken by people, usually with dosing charts alongside. FDA says it has warned companies that sold semaglutide, tirzepatide, retatrutide, survodutide or mazdutide this way, and that the products were sold directly to consumers for human use.^[8] The label is the seller’s own statement that the product is not for you, a point we take apart in what “research use only” means.

Vaguer still are programs that never say what you would get. Thryve advertises a “GLP-1 peptide program” without naming any drug, describing it only as a peptide currently under clinical research, and at the time of our review its Get Started button led to no intake at all.

Counterfeits. FDA says it is aware of counterfeit Ozempic marketed in the United States.^[8] In September 2026 federal prosecutors charged two men over counterfeit Ozempic allegedly sourced from China between July 2023 and April 2024, complete with fake packaging, package inserts, pen labels and needles, and sold to US distributors at deep discounts.^[12] An indictment is an allegation, not a conviction.

What test buyers found when they ordered without a prescription

A research team in Hungary and California searched for semaglutide online and then bought it. Of 1,080 search results they reviewed, 317 led to online pharmacies, and 134 of those, 42%, belonged to illegal operations. They placed orders with six sellers that sold semaglutide without a prescription.^[13]

• Three orders never arrived. All three were for Ozempic pens. The sellers instead asked for a further $650 to $1,200 to “clear customs”, which customs agencies confirmed was fraud.^[13]
• Three vials arrived, and all failed. The semaglutide in them was 7% to 14% pure, against the 99% printed on the labels. The amount of drug was 29% to 39% higher than the label said, so a user measuring by the label would inject more than intended.^[13]
• Every vial contained endotoxin, a bacterial contaminant, though none grew live bacteria.^[14] The authors classed all three as probable substandard and falsified products.^[14]

That is a small sample, six sellers already rated rogue or not recommended, with higher-priced offerings left out.^[13] It cannot say how common bad product is across the market, but it does show that the risks FDA lists for illegally sold GLP‑1s (too much drug, too little, or the wrong ingredients) are not hypothetical.^[8]

Getting the vial is only the first step. In a 2026 study, 20 adults were given gray-market-style semaglutide vials, diluent and supplies, and asked to prepare and inject a dose using only what they could find online. On average they completed 15 of the 34 required steps correctly, with errors that could lead to the wrong dose, needle-stick injuries or infection.^[15] FDA has separately reported adverse events, some needing hospital care, tied to people measuring the wrong dose of compounded semaglutide even with a prescriber involved.^[8]

The harms appear in safety reports. Europe’s adverse-event database holds 234 reports linked to suspected counterfeit semaglutide from 2018 to 2025; 89% of the reactions were classed as serious, and low blood sugar was reported more often than with genuine semaglutide.^[16] One published case describes an 18-year-old in Belgium who bought semaglutide online, raised her own dose without supervision and was admitted with ketoacidosis ten days later.^[17] She recovered. Reports like these show that harm happens; they cannot show how often.

What FDA has done about it

Our FDA warning letter register holds 157 letters that name GLP‑1 drugs, dated between October 2023 and September 2026. Of those, 60 are filed under unlawful or unapproved drug sales over the internet. A September 2026 letter to one internet pharmacy is typical: it says the site sold unapproved and misbranded injectable semaglutide, cites the prescription-dispensing section of the law, and warns that drugs which bypass regulatory safeguards “may be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether.”^[11]

FDA’s consumer advice on GLP‑1 drugs comes down to getting a prescription and filling it at a state-licensed pharmacy.^[8] Its BeSafeRx guidance lists a pharmacy that does not require a prescription, or that offers prices too good to be true, as a warning sign, and says that if an online pharmacy does not appear in your state board of pharmacy’s license database, you should not use it.^[9][10]

How to get a GLP-1 lawfully

A prescription does not have to mean an office visit. Telehealth prescribing is legal, and much of the GLP‑1 market runs through it. A legitimate one has a few features you can check for:

1. A licensed clinician reviews your history before anything is prescribed. FDA lists a company that does not require screening and a prescription by a licensed doctor as a red flag.^[8] An intake form that cannot produce a “no” is not a screening.
2. The prescriber is licensed in your state. Who the prescriber is should be stated, not hidden behind “our medical team.”
3. A named pharmacy fills it, and that pharmacy appears in your state board’s license database.^[10]
4. A pharmacist and a clinician are reachable afterward for dose changes and side effects.^[8][9]

The lawful routes differ more than that list suggests. CVS MinuteClinic starts with an online or walk-in visit and prescribes only FDA-approved drugs, which you then fill at a pharmacy through insurance or with a manufacturer coupon. LunaRx offers care in English and Spanish and says a patient who is not approved pays nothing, which is what a screening that can say no looks like. Vivanta Care names the pharmacy that fills its compounded prescriptions, and Glow names dispensing pharmacies too, though its website and its operator’s care page name different pairs.

Others leave more of the checklist to you. Vyvron and UR Meds are platforms rather than medical practices, with OpenLoop Health supplying the clinical side, and UR Meds does not name the drug, the dose or the pharmacy behind its program. Robinhood Telehealth names neither its prescribing group nor its pharmacy, so the second and third checks above are the ones to press on.

Intimate Rose, a pelvic-health brand, runs its GLP-1 program through OpenLoop Health’s clinicians and pharmacy network as well. It shows its starting price before the health questions. It also received an FDA warning letter over claims implying its compounded semaglutide and tirzepatide were the same as FDA-approved drugs.

Our guides on what makes a telehealth GLP-1 prescription legitimate and how to verify an online GLP-1 pharmacy walk through each check. Compounded semaglutide is prescription-only too; our compounded semaglutide prescription explainer covers why. Cash prices for the brand-name drugs have fallen and change often; current figures are on our price tracker and in semaglutide cost without insurance. A lower cash price still requires a prescription.

Is an over-the-counter GLP-1 coming?

There is no public sign of one. Federal law lets FDA lift the prescription requirement from a drug only when that requirement is not necessary to protect public health.^[7] For a drug whose labels carry warnings about pancreatitis, gallbladder disease, kidney injury from dehydration and thyroid tumors in rodents,^[2][22] that would be a large step, and no GLP‑1 maker has publicly announced an application to take it.

The one development that could matter later is a rule FDA finalized in December 2024. It created a category of nonprescription drug with an “additional condition for nonprescription use”: a drug that could be sold without a prescription if the company adds a condition that ensures buyers choose it appropriately, use it appropriately, or both.^[20] The rule sets up a route without deciding anything about a particular drug, and no GLP‑1 maker has announced plans to use it.

The weight-loss drug that is on pharmacy shelves is orlistat, sold as Alli. Its label is an over-the-counter label, for adults 18 and older who are overweight and following a reduced-calorie, low-fat diet.^[19] The label sets modest expectations: for every 5 pounds lost from diet alone, orlistat can help you lose 2 to 3 pounds more, and it warns of oily spotting and loose stools.^[19] It is not a GLP‑1 and it is not an over-the-counter version of Ozempic.